SCD and metabolic dysfunction-associated steatotic liver disease: Among these fatty acid synthetases, SCD-1 is a terminal enzyme controlling the DNL, and the induction of SCD-1 is highlighted to be a key player in the pathogenesis and progression of NAFLD (Jensen-Urstad and Semenkovich, 2012; Sanders and Griffin, 2016).